Denning, Naomi-Liza
Aziz, Monowar
Diao, Li
Prince, Jose M.
Wang, Ping http://orcid.org/0000-0002-1557-0394
Funding for this research was provided by:
National Institutes of Health (R01HL076179, R35GM118337, R01GM129633)
Article History
Received: 8 September 2020
Accepted: 12 November 2020
First Online: 4 December 2020
Ethics approval and consent to participate
: Human samples were studied under the approval of Institutional Review Board (Northwell Health IRB # 19–0511). All animal studies were performed under the approval of the Institutional Animal Care and Use Committee of the Feinstein Institutes for Medical Research.
: Yes.
: One of the authors (PW) is an inventor of patent applications (WO/2010/120726 and 61/881.798) covering the fundamental concept of targeting CIRP for the treatment of inflammatory diseases, licensed by TheraSource LLC. PW is a co-founder of TheraSource LLC. Other authors declared that they have no competing interests.